November 2020

Investment in Internal Process Development and Manufacturing Enables Rapid Product Development

Speed to the clinic and patient safety are important goals when working to bring novel genetic therapies to patients. To achieve these goals, Homology Medicines decided to invest in internal development and manufacturing operations not long after the Company’s founding, which included the construction of a 25,000 sq ft GMP manufacturing facility adjacent to its …

Investment in Internal Process Development and Manufacturing Enables Rapid Product Development Read More »

Mind the Gaps: A Perspective from the World of Academic Spinouts

Depending upon your perspective, “emerging” biotech could mean any number of things, ranging all the way from the recent spinout of an academic lab to a publicly held company developing a therapeutic that has not yet reached the marketplace. My company, Respana Therapeutics (a finalist in North America Advance Biotech Grant Program) sits at the …

Mind the Gaps: A Perspective from the World of Academic Spinouts Read More »

Scroll to Top